FDA is unsure whether Johnson & Johnson COVID-19 vaccine recipients need a ...

FDA is unsure whether Johnson & Johnson COVID-19 vaccine recipients need a ...
FDA is unsure whether Johnson & Johnson COVID-19 vaccine recipients need a ...
FDA is unsure whether Johnson & Johnson COVID-19 vaccine recipients need a booster - and if it should be given at two months or six months The FDA released a report Thursday showing little confidence in data submitted by J&J in hopes of getting its COVID-19 vaccine booster shot approved  An FDA advisory panel will meet on Friday to discuss whether the boosters are needed  J&J's vaccine is the only one-shot COVID-19 vaccine available in the U.S. and has been administered to more than 15 million people Public confidence in the shot has waned in recent months despite little changing about the science of the vaccine  In San Francisco, recipients of the shot are eligible to receive a 'supplemental' shot of either the Pfizer or Moderna vaccine, and CVS no longer offers the shot

View
comments

While COVID-19 vaccine boosters are beginning to roll out for recipients of the Pfizer-BioNTech and Moderna vaccines, Americans who received the Johnson & Johnson (J&J) vaccine remain in limbo.

The one-dose vaccine's booster is set to be discussed by a U.S. Food and Drug Administration (FDA) advisory panel on Friday, but a report released on Thursday does not show optimism in the J&J shot.

The FDA did not show confidence in the need for the booster, because the data from the New Brunswick, New Jersey-based company was lacking, including limited evidence that a second shot would help against the highly contagious Delta variant.

While the advisory committee could still vote in favor of the booster on Friday, a failure to receive recommendation would be yet another of a long lists of setbacks the company has faced during its vaccine rollout.  

An FDA advisory panel will discuss whether booster shots of the Johnson & Johnson COVID-19 vaccine (pictured) are needed for recipients six months after receiving the first shot. The agency did not show confidence in data submitted by the company in a recent report

An FDA advisory panel will discuss whether booster shots of the Johnson & Johnson COVID-19 vaccine (pictured) are needed for recipients six months after receiving the first shot. The agency did not show confidence in data submitted by the company in a recent report

The J&J vaccine's reputation has faltered in recent months. In April, its use was paused for two weeks after it was linked to six cases and one death of blood clotting in women. Pictured: A man in Saratoga, New York, receives a shot of the Johnson & Johnson COVID-19 vaccine on July 30

The J&J vaccine's reputation has faltered in recent months. In April, its use was paused for two weeks after it was linked to six cases and one death of blood clotting

read more from dailymail.....

NEXT Health service initiative offers patients a chance to see a GP on the same day ... trends now